Author:
García-Lledó Alberto,Gómez-Pavón Javier,González del Castillo Juan,Hernández-Sampelayo Teresa,Martín-Delgado Mari Cruz,Martín Sánchez Francisco Javier,Martínez-Sellés Manuel,Molero García José María,Moreno Guillén Santiago,Rodríguez-Artalejo Fernando,Ruiz-Galiana Julián,Cantón Rafael,De Lucas Ramos Pilar,García-Botella Alejandra,Bouza Emilio
Abstract
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.
Publisher
Sociedad Espanola de Quimioterapia
Subject
Microbiology (medical),Pharmacology,General Medicine